Charles River Laboratories InternationalCRL
紐約證券 · USD
278.35
-2.41
(-0.86%)
收盤 09/10 03:59 (UTC+8)
09/10 03:59 (UTC+8)
Charles River Laboratories InternationalCRL
278.35
-2.41
(-0.86%)
財務數據
損益表
- 10.12
- 10.26
- 10.10
- 10.03
- 9.84
- 10.32
- 10.05
- 9.94
- 9.96
- 10.04
- -0.19
- 1.44
- -1.59
- -0.71
- -1.83
- 4.87
- -2.64
- -1.06
- 0.16
- 0.83
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 1,004,078 | 995,830 | 994,227 | 1,004,852 | 1,032,135 | 984,168 | 1,002,549 | 1,009,763 | 1,026,117 | 1,011,560 |
營業成本 | 640,704 | 701,166 | 4,699,671 | -3,349,068 | 675,068 | 666,436 | 4,718,031 | 660,742 | 672,404 | 666,717 |
營業毛利 | 363,374 | 294,664 | -3,705,444 | 4,353,920 | 357,067 | 317,732 | -3,715,482 | 349,021 | 353,713 | 344,843 |
營業費用 | 243,486 | 174,767 | 1,627,128 | -1,204,985 | 256,933 | - | 1,542,017 | - | - | - |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 228,897 | 159,422 | 1,290,010 | -916,285 | 191,549 | 177,799 | 1,306,298 | 199,213 | 169,791 | 186,291 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 14,589 | 15,345 | 337,118 | -288,700 | 65,384 | 65,264 | 235,719 | 32,403 | 32,270 | 32,575 |
營業利益 | 119,888 | 119,897 | -283,440 | 133,799 | 100,134 | 74,669 | -167,687 | 117,405 | 151,652 | 125,977 |
其他收入及費用 | -36,378 | -123,097 | 13,116 | -21,196 | 1,251 | -10,807 | -20,870 | 4,120 | 770 | 8,035 |
利息費用 | 30,340 | 26,742 | 190,283 | -141,105 | 29,967 | 27,884 | 224,342 | 30,284 | 32,769 | 35,001 |
稅前純益 | 53,170 | -29,942 | -294,099 | 87,200 | 71,418 | 35,978 | -216,791 | 91,241 | 119,653 | 99,011 |
所得稅 | 53,930 | -15,140 | 103,129 | -89,294 | 18,725 | 10,100 | 138,690 | 20,946 | 25,392 | 24,529 |
稅後純益 | -1,482 | -14,843 | -276,555 | 54,422 | 52,326 | 25,469 | -214,495 | 69,657 | 94,081 | 72,960 |
基本每股稅後盈餘(元) | -0.03 | -0.30 | -5.62 | 1.11 | 1.06 | 0.50 | -4.22 | 1.34 | 1.75 | 1.31 |
稀釋每股稅後盈餘(元) | -0.04 | -0.30 | -5.56 | 1.10 | 1.05 | 0.50 | -4.17 | 1.33 | 1.74 | 1.30 |
基本平均股數(千股) | 48021.00 | 48951.00 | 49216.00 | 49213.00 | 49149.00 | 50677.00 | 51138.00 | 51394.00 | 51551.00 | 51437.00 |
稀釋平均股數(千股) | 48021.00 | 48951.00 | 49216.00 | 49426.00 | 49316.00 | 50853.00 | 51138.00 | 51583.00 | 51846.00 | 51842.00 |
還原基本每股稅後盈餘(元) | -0.03 | -0.30 | -5.62 | 1.11 | 1.06 | 0.50 | -4.22 | 1.34 | 1.75 | 1.31 |
還原稀釋每股稅後盈餘(元) | -0.04 | -0.30 | -5.56 | 1.10 | 1.05 | 0.50 | -4.17 | 1.33 | 1.74 | 1.30 |
還原基本平均股數(千股) | 48,021 | 48,951 | 49,216 | 49,213 | 49,149 | 50,677 | 51,138 | 51,394 | 51,551 | 51,437 |
還原稀釋平均股數(千股) | 48,021 | 48,951 | 49,216 | 49,426 | 49,316 | 50,853 | 51,138 | 51,583 | 51,846 | 51,842 |
EBITDA(千元) | 150,078 | 63,910 | 95,134 | -90,813 | 220,525 | 183,817 | 250,641 | 209,085 | 238,324 | 217,847 |